Results 211 to 216 of about 7,826 (216)

Comparative Study of the Hemostatic Efficacy of a New Human Fibrin Sealant: Is an Antifibrinolytic Agent Necessary?

, 2002
Bijan S. Kheirabadi, Rebecca Pearson, David Tuthill, Kiti Rudnicka, John B. Holcomb, William N. Drohan, Martin J. MacPhee   +6 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Targeting Apoptosis Pathways in Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

Ca-A Cancer Journal for Clinicians, 2013
exaly  

Chronic Inflammation: A Common and Important Factor in the Pathogenesis of Neoplasia

Ca-A Cancer Journal for Clinicians, 2006
exaly  

Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment

Ca-A Cancer Journal for Clinicians, 2009
exaly  

[Therapy of an experimentally induced radiation syndrome in the rat using brain phospholipids and an antifibrinolytic agent (AMCHA)].

, 1973
Spreafico Pl, G Galetti, S Cuttin
openalex